Cargando…
Targeted Nanotechnology in Glioblastoma Multiforme
Gliomas, and in particular glioblastoma multiforme, are aggressive brain tumors characterized by a poor prognosis and high rates of recurrence. Current treatment strategies are based on open surgery, chemotherapy (temozolomide) and radiotherapy. However, none of these treatments, alone or in combina...
Autores principales: | Glaser, Talita, Han, Inbo, Wu, Liquan, Zeng, Xiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5374154/ https://www.ncbi.nlm.nih.gov/pubmed/28408882 http://dx.doi.org/10.3389/fphar.2017.00166 |
Ejemplares similares
-
Nanotechnology for Treatment of Glioblastoma Multiforme
por: Michael, Justin S., et al.
Publicado: (2018) -
Apatinib for recurrent/progressive glioblastoma multiforme: A salvage option
por: Zhang, Hong-Hong, et al.
Publicado: (2022) -
Induction of Mitosis Delay and Apoptosis by CDDO-TFEA in Glioblastoma Multiforme
por: Tsai, Tai-Hsin, et al.
Publicado: (2021) -
Combined-therapeutic strategies synergistically potentiate glioblastoma multiforme treatment via nanotechnology
por: Yang, Jun, et al.
Publicado: (2020) -
Modulation of Tumor Immune Microenvironment and Prognostic Value of Ferroptosis-Related Genes, and Candidate Target Drugs in Glioblastoma Multiforme
por: Zhang, Xudong, et al.
Publicado: (2022)